"We feel he didn't get the medicine and treatment for the disease because he's African and they don't consider him as important as the other three," Josephus Weeks, Duncan's nephew, said at a press conference Tuesday afternoon.
Jesse Jackson, who attended the press conference with Weeks and Duncan's mother as a newly appointed spokesman for the family, added, "We don't feel good about that.
He started receiving the experimental drug, brincidofovir, on October 4.
Weeks, though, said his uncle is "doing better" -- he's still on dialysis, but his heart rate has improved, his blood pressure is "normal," "his fever is pretty much gone" and his diarrhea has "slowed."
"The care team has been consulting with the CDC and Emory, on a daily basis since Mr. Duncan was admitted to the hospital, discussing the possible course of treatment, including the use of investigational drugs," hospital spokesman Wendell Watson said in a statement.
Weeks said he and his family had to "pressure" the hospital to apply for permission to give the drug, brincidofovir, to Duncan.
Dr. Kent Brantley and Nancy Writebol -- both treated at Emory -- took Zmapp, which is no longer available because the company ran out of supplies of the drug.